Klemens Ablasser

1.0k total citations
33 papers, 524 citations indexed

About

Klemens Ablasser is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Klemens Ablasser has authored 33 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Klemens Ablasser's work include Cardiovascular Function and Risk Factors (11 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Parathyroid Disorders and Treatments (4 papers). Klemens Ablasser is often cited by papers focused on Cardiovascular Function and Risk Factors (11 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Parathyroid Disorders and Treatments (4 papers). Klemens Ablasser collaborates with scholars based in Austria, Germany and United States. Klemens Ablasser's co-authors include Pedro J. del Nido, Ingeborg Friehs, Assunta Fabozzo, Yuhan Lee, Eoin D. O’Cearbhaill, Robert F. Padera, Eric N. Feins, Nora Lang, Maria Pereira and Nikolay V. Vasilyev and has published in prestigious journals such as PLoS ONE, European Heart Journal and Science Translational Medicine.

In The Last Decade

Klemens Ablasser

28 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klemens Ablasser Austria 10 197 140 108 102 93 33 524
В. Г. Матвеева Russia 15 215 1.1× 116 0.8× 318 2.9× 169 1.7× 126 1.4× 96 706
Nina Klingman United States 10 182 0.9× 100 0.7× 128 1.2× 45 0.4× 65 0.7× 16 523
Yongquan Gu China 14 350 1.8× 47 0.3× 207 1.9× 95 0.9× 96 1.0× 82 746
Juan C. Briceño Colombia 12 258 1.3× 35 0.3× 262 2.4× 294 2.9× 110 1.2× 52 800
Raila Busch Germany 9 130 0.7× 67 0.5× 85 0.8× 53 0.5× 40 0.4× 18 308
Tsunehisa Sakurai Japan 13 260 1.3× 61 0.4× 107 1.0× 62 0.6× 66 0.7× 30 608
Chee Hoe Kong Singapore 12 139 0.7× 86 0.6× 81 0.8× 177 1.7× 52 0.6× 19 480
Rosy Eloy France 12 209 1.1× 34 0.2× 48 0.4× 52 0.5× 39 0.4× 36 534
Geesien S.A. Boersema Netherlands 16 412 2.1× 131 0.9× 52 0.5× 70 0.7× 38 0.4× 24 570
Zhenjun Yao China 12 296 1.5× 22 0.2× 54 0.5× 94 0.9× 121 1.3× 24 588

Countries citing papers authored by Klemens Ablasser

Since Specialization
Citations

This map shows the geographic impact of Klemens Ablasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klemens Ablasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klemens Ablasser more than expected).

Fields of papers citing papers by Klemens Ablasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klemens Ablasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klemens Ablasser. The network helps show where Klemens Ablasser may publish in the future.

Co-authorship network of co-authors of Klemens Ablasser

This figure shows the co-authorship network connecting the top 25 collaborators of Klemens Ablasser. A scholar is included among the top collaborators of Klemens Ablasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klemens Ablasser. Klemens Ablasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cejka, Vladimir, Ewald Kolesnik, David Zach, et al.. (2025). Prognostic Impact of Gait Speed, Muscle Strength and Muscle Mass in Chronic Heart Failure—A Prospective Cohort Study. ESC Heart Failure. 12(3). 2113–2124.
2.
Lewinski, Friederike von, Franz Quehenberger, Michael Sacherer, et al.. (2024). Air Pollution and Myocardial Infarction—A New Smoker’s Paradox?. Journal of Clinical Medicine. 13(23). 7324–7324. 1 indexed citations
3.
Zach, David, Markus Wallner, Dirk von Lewinski, et al.. (2024). Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study. Journal of Clinical Medicine. 13(19). 5966–5966. 7 indexed citations
4.
Zach, David, Alexander Peikert, Peter P. Rainer, et al.. (2024). The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure—A Prospective Study. Journal of Clinical Medicine. 13(7). 1930–1930. 5 indexed citations
5.
Kolesnik, Ewald, Markus Wallner, Klemens Ablasser, et al.. (2024). Impact of the Timing of Mechanical Circulatory Support on the Outcomes in Myocardial Infarction-Related Cardiogenic Shock: Subanalysis of the PREPARE CS Registry. Journal of Clinical Medicine. 13(6). 1552–1552. 1 indexed citations
6.
Sokolski, Mateusz, Sander Trenson, Tor Biering‐Sørensen, et al.. (2024). Phenotype clustering of hospitalized high-risk patients with COVID-19 — a machine learning approach within the multicentre, multinational PCHF-COVICAV registry. Cardiology Journal. 31(4). 512–521. 2 indexed citations
7.
Posch, Florian, Markus Wallner, Peter P. Rainer, et al.. (2023). Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort. European Journal of Internal Medicine. 118. 73–81. 2 indexed citations
8.
Lewinski, Dirk von, Heiko Bugger, Ewald Kolesnik, et al.. (2023). Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort. Journal of Clinical Medicine. 12(22). 6988–6988. 2 indexed citations
9.
Zach, David, Ewald Kolesnik, Hubert Seggewiß, et al.. (2023). Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy. International Journal of Cardiology. 399. 131661–131661. 4 indexed citations
10.
Achim, Alexandru, Albrecht Schmidt, Klemens Ablasser, et al.. (2023). Transesophageal echocardiography‐guided versus fluoroscopy‐guided patent foramen ovale closure: A single center registry. Echocardiography. 40(7). 657–663. 5 indexed citations
11.
Verheyen, Nicolas, Kathrin Danninger, Franz Duca, et al.. (2022). Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis—A Retrospective Austrian Multicenter Study. Biomedicines. 10(12). 3052–3052. 2 indexed citations
12.
Zach, David, Klemens Ablasser, Ewald Kolesnik, et al.. (2021). Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry. Genes. 12(10). 1469–1469. 12 indexed citations
13.
Zach, David, Klemens Ablasser, Ewald Kolesnik, et al.. (2021). Advanced Isolated Light Chain Amyloid Cardiomyopathy with Negative Immunofixation and Normal Free Light Chain Ratio. ESC Heart Failure. 8(4). 3397–3402. 1 indexed citations
14.
Verheyen, Nicolas, Astrid Fahrleitner‐Pammer, Evgeny Belyavskiy, et al.. (2017). Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial. PLoS ONE. 12(4). e0173799–e0173799. 9 indexed citations
15.
Nikolova, Andriana, Klemens Ablasser, Moritz C. Wyler von Ballmoos, et al.. (2012). Endogenous Angiogenesis Inhibitors Prevent Adaptive Capillary Growth in Left Ventricular Pressure Overload Hypertrophy. The Annals of Thoracic Surgery. 94(5). 1509–1517. 23 indexed citations
16.
Gasser, S, Klemens Ablasser, Ingeborg Friehs, et al.. (2010). Shift from Adult to Fetal Metabolic Phenotype During Prolonged Experimental Myocardial Ischemia: A Study on the Effect of Beta Blockers upon Gene Expression of Transmembrane Glucose Transporters. Journal of clinical and basic cardiology. 12(1). 11–17.
17.
Kaza, Evangelia, Klemens Ablasser, Eric R. Griffiths, et al.. (2010). Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium. Cardiovascular Research. 89(2). 410–418. 27 indexed citations
18.
Gasser, R., S Gasser, Klemens Ablasser, et al.. (2008). Quantification of GLUT4 Gene Expression in Human Atrial Myocardium of Hypertensive Patients and the Effect of Experimental Ischaemia Thereupon. Journal of clinical and basic cardiology. 10(1). 1–6.
19.
Gasser, R., Klemens Ablasser, S Gasser, et al.. (2007). A Microarray and Real Time PCR Study on the Effect of Experimental Ischemia upon the Expression of the Insulin-Dependent Transmembrane Glucose Transport Molecule GLUT4 in Human Atrial Myocardium. Journal of clinical and basic cardiology. 9(1). 4–9. 3 indexed citations
20.
Gasser, R., et al.. (2007). Letters to the editor: Effects of Nebivolol on Myocardial Gene Expression during N2-stimulated Ischemia in Human Atrial Myocardium. Journal of clinical and basic cardiology. 9(1). 42–44.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by В. Г. Матвеева Breakdown of academic impact, for papers by Nina Klingman Breakdown of academic impact, for papers by Yongquan Gu Breakdown of academic impact, for papers by Juan C. Briceño Breakdown of academic impact, for papers by Raila Busch Breakdown of academic impact, for papers by Tsunehisa Sakurai Breakdown of academic impact, for papers by Chee Hoe Kong Breakdown of academic impact, for papers by Rosy Eloy Breakdown of academic impact, for papers by Geesien S.A. Boersema Breakdown of academic impact, for papers by Zhenjun Yao
Rankless by CCL
2026